Obfuscated Drug Test Kit Selective Reporting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing drug testing systems face challenges in maintaining user privacy and compliance with varying regulatory requirements, as they often provide unnecessary test results, leading to logistical and cost issues due to the need for a wide range of test kits and potential breaches in medical confidentiality.
Innovation Solution
A system comprising a standardized diagnostic test kit and reader that allows operators to select specific assays and only report authorized results, using obfuscation codes to obscure unauthorized test results, and a computerized device with a network interface to manage and transmit data securely.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a standardized test kit with multiple analytes is used to reduce costs and logistics complexity, then manufacturing efficiency and cost are improved, but user privacy and regulatory compliance deteriorate due to exposure of unauthorized test results
Solution Approach 1:
The patent extracts only the authorized subset of test results from the complete test panel and makes them available to the user. The system performs all tests but selectively reports only those results that the user is authorized to view, thereby preventing privacy breaches while maintaining the efficiency of standardized test kits.
Solution Approach 2:
The patent introduces a result filtering and reporting system that acts as an intermediary between the test kit and the user. This intermediary selectively transmits only authorized results to the user interface, preventing unauthorized information exposure while maintaining the benefits of standardized multi-analyte testing.
2Adaptability or versatility
If multiple different customized test kits are provided to meet varying regulatory requirements of different institutions, then user-specific compliance is improved, but device complexity and logistical burden worsen
Solution Approach 1:
The patent implements a universal test kit design that can perform multiple different analyte tests simultaneously. The system includes a comprehensive panel of tests that can accommodate various regulatory requirements, and through selective reporting, provides only the relevant results for each user's specific compliance needs, eliminating the need for multiple specialized kits.
Solution Approach 2:
The patent introduces dynamic configurability where the test panel and result reporting can be adjusted based on user authorization and regulatory requirements. The system can dynamically select which tests to perform and which results to report, providing adaptability to different institutions' needs without requiring physically different test kits.
3Loss of information
If all test results are reported to the user, then measurement completeness is improved, but medical confidentiality and user privacy worsen
Solution Approach 1:
The patent extracts and reports only the specific subset of test results that the user is authorized to view. The system maintains all test data internally but selectively presents only the relevant results to the user interface, preventing confidentiality breaches while ensuring that users receive complete information within their authorization scope.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach reduces costs by standardizing test kits, enhances user privacy by limiting reported results to those authorized, and ensures compliance with diverse regulatory requirements through secure and controlled data transmission.
Implementation Method 1
antibodies specific to various types of drugs may be immobilized at different locations on the surface of different bibulous membrane tracks
Implementation Method 2
A test sample suspected of containing one or more drugs is applied to the bottom of the various tracks, a carrier fluid is applied along
Data Source
AI summary
Point of care drug of abuse test system configured to allow a small number of general test kits to be used to analyze many different combinations of analytes, while preserving privacy and the chain of custody. The system uses disposable multiple-analyte test kits and allows the operator to select which subset of kit analytes to run. The computerized device images the test kits and transmits test results to a remote server along with a test specific ID code. The test kit is often obfuscated so that the local operator cannot interpret the results. Other donor information, such as driver's licenses and signatures, are also obtained and transmitted as well. The remote server uses the test specific ID code to retrieve an obfuscation code (answer key) from the server's database, allowing the server to interpret the results. The annotated results are transmitted to a recipient along with suitable donor verification information.